Replies to post #2040 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>Cabilly II may ultimately be avoided by MEDX, MEDI and JNJ/CNTO as a result<

Are they the only ones on the hook for Cabilly II royalties? Why not others too? T.i.a.